Table 3 Cumulative mortality and hazards ratios (95% confidence interval) for all-cause mortality associated with quartile of standard deviation (SD), coefficient of variation (CV), and average real variability (ARV) of resting heart rate (RHR).

From: Elevated Long Term Resting Heart Rate Variation is Associated with Increased Risk of All-cause Mortality in Northern China

 

Quartile of RHR-SD, bpm

P for trend

Quartile 1 (<3.6)

Quartile 2 (3.6–5.8)

Quartile 3 (5.8–8.5)

Quartile 4 (≥8.5)

Total, n

11,676

12,230

10,912

12,055

Deaths, n (%)

168 (1.4)

207 (1.7)

269 (2.5)

329 (2.7)

<0.001

Model 1*

1.00 (Ref)

1.18 (0.96–1.45)

1.73 (1.42–2.09)

1.91 (1.58–2.30)

<0.001

Model 2

1.00 (Ref)

1.17 (0.95–1.43)

1.64 (1.36–1.99)

1.72 (1.43–2.07)

<0.001

Model 3

1.00 (Ref)

1.16 (0.94–1.43)

1.51 (1.24–1.84)

1.43 (1.18–1.74)

<0.001

 

Quartile of RHR-CV, %

 

Quartile 1 (<5.0)

Quartile 2 (5.0–7.9)

Quartile 3 (7.9–11.7)

Quartile 4 (≥11.7)

P for trend

Total, n

11,471

11,795

11,742

11,693

Deaths, n (%)

172 (1.5)

206 (1.7)

284 (2.4)

311 (2.7)

<0.001

Model 1*

1.00 (Ref)

1.19 (0.97–1.45)

1.65 (1.37–2.00)

1.81 (1.50–2.18)

<0.001

Model 2

1.00 (Ref)

1.16 (0.95–1.42)

1.55 (1.28–1.88)

1.57 (1.30–1.89)

<0.001

Model 3

1.00 (Ref)

1.16 (0.95–1.43)

1.49 (1.23–1.81)

1.41 (1.16–1.71)

<0.001

 

Quartile of RHR-ARV, bpm

 

Quartile 1 (<4.0)

Quartile 2 (4.0–7.0)

Quartile 3 (7.0–11.0)

Quartile 4 (≥11.0)

P for trend

Total, n

9,337

13,092

12,312

12,132

Deaths, n (%)

125 (1.3)

237 (1.8)

292 (2.4)

319 (2.6)

<0.001

Model 1*

1.00 (Ref)

1.36 (1.08–1.67)

1.77 (1.44–2.18)

1.96 (1.59–2.41)

<0.001

Model 2

1.00 (Ref)

1.32 (1.06–1.63)

1.66 (1.35–2.05)

1.79 (1.45–2.20)

<0.001

Model 3

1.00 (Ref)

1.23 (0.99–1.54)

1.50 (1.21–1.86)

1.43 (1.16–1.78)

0.001

  1. *Unadjusted model.
  2. Adjusted for age and gender.
  3. Adjusted for age, gender, body mass index, current smoker, mean systolic blood pressure, mean resting heart rate, fasting plasma glucose, total cholesterol, high density lipoprotein, elevated C-reactive protein and ACE inhibitor.